` IMNM (Immunome Inc) vs S&P 500 Comparison - Alpha Spread

IMNM
vs
S&P 500

Over the past 12 months, IMNM has significantly outperformed S&P 500, delivering a return of +95% compared to the S&P 500's +14% growth.

Stocks Performance
IMNM vs S&P 500

Loading
IMNM
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
IMNM vs S&P 500

Performance Gap Between IMNM and GSPC
HIDDEN
Show

Performance By Year
IMNM vs S&P 500

Loading
IMNM
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Immunome Inc vs Peers

S&P 500
IMNM
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Immunome Inc
Glance View

Market Cap
2B USD
Industry
Biotechnology

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. The company is headquartered in Exton, Pennsylvania and currently employs 39 full-time employees. The company went IPO on 2020-10-02. The firm's primary focus areas are oncology and infectious diseases. Its discovery platform identifies therapeutic antibodies and their targets by leveraging components of the immune system, memory B cells, from patients who have learned to fight off their disease. Its lead discovery programs include IMM-ONC-01 and IMM-BCP-01. IMM-ONC-01, is its lead oncology program, which is focused on IL-38. IMM-BCP-01, is its lead infectious disease discovery program with a focus on SARS-CoV-2, the virus that causes COVID-19. The firm is developing an antibody cocktail product candidate by identifying a combination of anti-viral antibodies produced by B cells from COVID-19 super-responders.

IMNM Intrinsic Value
HIDDEN
Show
Back to Top